<DOC>
	<DOCNO>NCT00436540</DOCNO>
	<brief_summary>The primary objective study evaluate efficacy safety clobetasol propionate 0.05 % ( Clobex® ) spray compare clobetasol propionate 0.05 % ( Olux® ) foam .</brief_summary>
	<brief_title>A Comparison Between Clobetasol Propionate 0.05 % ( Clobex® ) Spray Clobetasol Propionate 0.05 % ( Olux® ) Foam</brief_title>
	<detailed_description>Same .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Clobetasol</mesh_term>
	<criteria>Subjects must clinical diagnosis moderate severe plaque psoriasis , define 3 % 20 % body surface area involve Subjects surface area involvement large would require 50 gram per week Clobex® spray 50 gram per week Olux® foam Subjects whose psoriasis involve scalp , face groin Subjects nonplaque psoriasis relate disease classify plaque psoriasis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2008</verification_date>
</DOC>